Ignite Creation Date:
2024-10-25 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06654297
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-20
Brief Title:
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
Sponsor:
Organization:
None